These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 400195)

  • 1. [Clinical experiences with radiotherapy and ICRF 159 in sarcomas].
    Rhomberg W; Mesche E; Gefeller D; Hassenstein E
    Strahlentherapie Sonderb; 1978; 75():110-4. PubMed ID: 400195
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy and ICRF 159 in the treatment of soft tissue sarcomas.
    Ryall RD
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):133-4. PubMed ID: 632140
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy combined with ICRF 159 (NSC 129943).
    Rhomberg WU
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):121-6. PubMed ID: 204615
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical evaluation of ICRF 159 as a radiosensitising agent.
    Bates T
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):127-31. PubMed ID: 344288
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.
    Hellmann K; Ryall RD; Macdonald E; Newton KA; James SE; Jones S
    Cancer; 1978 Jan; 41(1):100-7. PubMed ID: 414829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report on AT1727 as a potential radiosensitizer.
    Zhang ZY; Liu TF; Zhang XF
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2305-7. PubMed ID: 6392223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas.
    Borden EC; Ash A; Enterline HT; Rosenbaum C; Laucius JF; Paul AR; Falkson G; Lerner H
    Am J Clin Oncol; 1982 Aug; 5(4):417-20. PubMed ID: 6956236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of ICRF-159 in non-Hodgkin's lymphomas.
    Flannery EP; Corder MP; Sheehan WW; Pajak TF; Bateman JR
    Cancer Treat Rep; 1978 Mar; 62(3):465-7. PubMed ID: 348318
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of neoadjuvant radiochemotherapy in undifferentiated soft tissue sarcomas].
    Stuschke M
    Strahlenther Onkol; 1994 Aug; 170(8):480-3. PubMed ID: 8085215
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of advanced adenocarcinoma of the kidney with ICRF-187: a Southeastern Cancer Study Group Trial.
    Brubaker LH; Vogel CL; Einhorn LH; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):915-6. PubMed ID: 3087618
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fast neutrons in the treatment of soft tissue sarcomas].
    Chernichenko VA; Tolstopiatov BA; Monich AIu; Konovalenko VF; Galakhin KA; Palivets AIu; Vorona AM
    Vopr Onkol; 1990; 36(11):1308-12. PubMed ID: 2281634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy and ECRF 159 (NCS 129943) in the treatment of inoperable soft-tissue sarcoma (author's transl)].
    Rhomberg W; Hellmann K; Ryall RD
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2438-42. PubMed ID: 4217269
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined treatment of lung carcinoma. Report on a prospective randomized study with radiotherapy and ICRF 159 (1,2-(3,5-dioxopiperazines-lyl)propane) (author's transl)].
    Hassenstein E; Rhomberg W
    Med Klin; 1977 Feb; 72(5):171-5. PubMed ID: 403395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation as a therapeutic modality in sarcomas of the soft tissue.
    Suit H; Spiro I
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):733-46. PubMed ID: 7490238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant radiation-doxorubicin administration in locally advanced and/or metastatic soft tissue sarcomas: preliminary results.
    Toma S; Palumbo R; Sogno G; Canavese G; Barra S; Marziano C; Serrano J; Albanese E; Rosso R
    Anticancer Res; 1991; 11(6):2085-9. PubMed ID: 1776844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant chemo-radiotherapy in the treatment of locally advanced and/or metastatic soft tissue sarcomas: experience of the National Cancer Institute of Genoa.
    Toma S; Canavese G; Grimaldi A; Ravera G; Ugolini D; Percivale P; Badellino F
    Oncol Rep; 2003; 10(3):641-7. PubMed ID: 12684637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Razoxane and vindesine in advanced soft tissue sarcomas: impact on metastasis, survival and radiation response.
    Rhomberg W; Eiter H; Schmid F; Saely C
    Anticancer Res; 2007; 27(5B):3609-14. PubMed ID: 17972524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas.
    Rosenberg SA
    Cancer Treat Rep; 1984 Sep; 68(9):1067-78. PubMed ID: 6383604
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.
    Rhomberg W; Hassenstein EO; Gefeller D
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1077-84. PubMed ID: 8985029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.
    Bellet RE; Engstrom PF; Catalano RB; Creech RH; Mastrangelo MJ
    Cancer Treat Rep; 1976 Sep; 60(9):1395-7. PubMed ID: 1016973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.